,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,3.8262498605297e-11,3.14900363521595e-08
2,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,3.60751376954066e-08,1.48449191616598e-05
3,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,6.94049700728837e-08,1.90400967899944e-05
4,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,3.08401826205184e-07,6.34536757417167e-05
5,WP_ZINC_HOMEOSTASIS,24,Up,7.62190924428828e-05,0.0106021019248847
6,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,9.71905770857849e-05,0.0106021019248847
7,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,9.73627959669751e-05,0.0106021019248847
8,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,0.000103058098905319,0.0106021019248847
9,WP_MEVALONATE_PATHWAY,7,Down,0.000118771472711534,0.0108609913379547
10,WP_ESTROGEN_METABOLISM_WP5276,10,Up,0.000206134042830813,0.0169648317249759
11,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.000259380342006823,0.0194063655883287
12,WP_COMPLEMENT_ACTIVATION,14,Up,0.000400782283133671,0.0274869849182509
13,WP_IRINOTECAN_PATHWAY,5,Up,0.000587937290511478,0.0372209530839189
14,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.00108786625744976,0.063950994991511
15,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.00137447105784977,0.0754126453740241
16,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,63,Up,0.00148209955883058,0.0762354960573481
17,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.00176080045607494,0.0809950487242055
18,WP_G13_SIGNALING,30,Down,0.0017714591458514,0.0809950487242055
19,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.00209992115219662,0.0909597425398853
20,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.00244861949927247,0.0961279193617731
21,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.00251251649828943,0.0961279193617731
22,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.00270047471759147,0.0961279193617731
23,WP_GABA_RECEPTOR_SIGNALING,10,Down,0.00291162443339004,0.0961279193617731
24,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.00291976439084833,0.0961279193617731
25,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.00296979720183736,0.0961279193617731
26,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,31,Down,0.00313901468855476,0.0961279193617731
27,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.00315364984540446,0.0961279193617731
28,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.00341470073520212,0.100367810895405
29,WP_MICROTUBULE_CYTOSKELETON_REGULATION,36,Down,0.00353704685910494,0.100378950518737
30,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.00494174912733537,0.131622393488482
31,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Down,0.00535400525928197,0.131622393488482
32,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.0054201191667822,0.131622393488482
33,WP_SPINAL_CORD_INJURY,69,Down,0.00542945740264742,0.131622393488482
34,WP_MATRIX_METALLOPROTEINASES,8,Up,0.0054753282957943,0.131622393488482
35,WP_TAMOXIFEN_METABOLISM,2,Up,0.00577950721730611,0.131622393488482
36,WP_EBOLA_VIRUS_INFECTION_IN_HOST,109,Down,0.00582553835525888,0.131622393488482
37,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Up,0.00591813762916821,0.131622393488482
38,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.00607734016107207,0.131622393488482
39,WP_NEUROINFLAMMATION,10,Down,0.00635476040605753,0.134101738825265
40,WP_16P112_DISTAL_DELETION_SYNDROME,24,Up,0.00673422096462886,0.13644476635383
41,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.00685380592444655,0.13644476635383
42,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.00696315940080297,0.13644476635383
43,WP_GASTRIN_SIGNALING,95,Down,0.00726704091836619,0.139087783158497
44,WP_PPAR_SIGNALING,39,Up,0.00784097952291487,0.146661957894521
45,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Down,0.0086438656963673,0.15808669929134
46,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.00932982514476014,0.166922741176904
47,WP_PDGF_PATHWAY,37,Down,0.00963156477920665,0.168654847091214
48,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.0105444007361823,0.180792537622459
49,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Down,0.012556186031777,0.207955686864865
50,WP_IRON_METABOLISM_IN_PLACENTA,10,Up,0.0126340028471971,0.207955686864865
51,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.0132584765149888,0.210670176803513
52,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0136502902353928,0.210670176803513
53,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,19,Down,0.0141195298091653,0.210670176803513
54,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.0141595383465333,0.210670176803513
55,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0143621999239025,0.210670176803513
56,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.0145891885002842,0.210670176803513
57,WP_WNT_SIGNALING_WP428,61,Down,0.0145907655866346,0.210670176803513
58,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0149546049250887,0.21220068712669
59,WP_COMPLEMENT_SYSTEM,55,Up,0.0152525390601131,0.212759994008018
60,WP_COMPLEMENT_AND_COAGULATION_CASCADES,31,Up,0.0161878390461169,0.218403139917282
61,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,31,Up,0.0161878390461169,0.218403139917282
62,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0171082502874893,0.227098225590382
63,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0174550960680639,0.228024508952644
64,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0178956643404536,0.230127058628021
65,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.020341663815297,0.250162397111257
66,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,107,Down,0.0206576267759388,0.250162397111257
67,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.0207449959960201,0.250162397111257
68,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0209256640310265,0.250162397111257
69,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,42,Down,0.020973518105318,0.250162397111257
70,WP_NRF2_PATHWAY,76,Up,0.0217720905827343,0.252777031831302
71,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.0218070100364793,0.252777031831302
72,WP_PROSTAGLANDIN_SIGNALING,23,Down,0.0226090684507857,0.258434212986064
73,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.0240469677631312,0.271104855740507
74,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0244535404939388,0.27196302468259
75,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.0262493838956638,0.285555754293507
76,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.0264240882643535,0.285555754293507
77,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.0269902330039972,0.285555754293507
78,WP_EGFEGFR_SIGNALING,143,Down,0.0272540609203397,0.285555754293507
79,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0276020301789379,0.285555754293507
80,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.0280005627416182,0.285555754293507
81,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.0281045153071373,0.285555754293507
82,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,25,Down,0.0288277689834192,0.289332364309195
83,WP_NOTCH_SIGNALING_WP268,36,Down,0.0298619058933797,0.296100584942789
84,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Down,0.0303114307500579,0.296979851277353
85,WP_SPHINGOLIPID_PATHWAY,21,Down,0.0310489536119179,0.300626927324805
86,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.0314671759682469,0.30108822494006
87,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Down,0.0318282813727645,0.30108822494006
88,WP_WNT_SIGNALING_WP363,39,Down,0.0326820091423494,0.305651062774473
89,WP_VITAMIN_B12_METABOLISM,27,Up,0.0341633346357094,0.315914880957178
90,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,50,Down,0.0346647878814673,0.31695756137142
91,WP_P38_MAPK_SIGNALING,31,Down,0.0354774640925743,0.31695756137142
92,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.036515052963341,0.31695756137142
93,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,50,Down,0.0376023152333895,0.31695756137142
94,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.0376053780670348,0.31695756137142
95,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,23,Down,0.0376187176381078,0.31695756137142
96,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.0376620548883993,0.31695756137142
97,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.037888737373482,0.31695756137142
98,WP_CHOLESTEROL_METABOLISM,53,Down,0.0379955467685703,0.31695756137142
99,WP_COPPER_HOMEOSTASIS,40,Up,0.0385235647616083,0.31695756137142
100,WP_15Q25_COPY_NUMBER_VARIATION,29,Up,0.038611529578613,0.31695756137142
101,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,57,Down,0.038897586510952,0.31695756137142
102,WP_ERBB_SIGNALING,69,Down,0.0395069395500819,0.318766776958014
103,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.0405877095187056,0.324307620717424
104,WP_NRF2ARE_REGULATION,20,Up,0.0415641365943349,0.327761674245317
105,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.0418164954990987,0.327761674245317
106,WP_HEART_DEVELOPMENT,19,Down,0.0426919606124925,0.329912532672438
107,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Down,0.042892637905165,0.329912532672438
108,WP_MAPK_SIGNALING,166,Down,0.0437156099199678,0.330537033970078
109,WP_HYPERTROPHY_MODEL,14,Down,0.0437770798332181,0.330537033970078
110,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Up,0.0443931074637968,0.332141158570043
111,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,71,Down,0.045185299889525,0.332516820149651
112,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0455824017627536,0.332516820149651
113,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.0456554078698791,0.332516820149651
114,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.0475630435009788,0.342477634052353
115,WP_MAPK_CASCADE,30,Down,0.047996626507963,0.342477634052353
116,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.0482714526732356,0.342477634052353
117,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,62,Down,0.04902032521877,0.343324169621081
118,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.0496387032201278,0.343324169621081
119,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.0496652460705699,0.343324169621081
120,WP_PANCREATIC_CANCER_SUBTYPES,6,Up,0.0508169054527804,0.343324169621081
121,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.0514838540024413,0.343324169621081
122,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.0516813729142296,0.343324169621081
123,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.0516877083965391,0.343324169621081
124,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.0517280644386562,0.343324169621081
125,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.0574230346496397,0.377150385249154
126,WP_GPCRS_OTHER,17,Down,0.057745592141617,0.377150385249154
127,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,14,Down,0.0583011846251647,0.377150385249154
128,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,77,Down,0.0586576540849231,0.377150385249154
129,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Down,0.0602738096071841,0.384537560517151
130,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.0607895508302707,0.38484461794856
131,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,16,Down,0.0616513198398578,0.387320887238191
132,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.0629915531409156,0.39274278965889
133,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.0653038674188239,0.400013562759209
134,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.06550224411305,0.400013562759209
135,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.0662725636640801,0.400013562759209
136,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0664272171638025,0.400013562759209
137,WP_MACROPHAGE_MARKERS,9,Up,0.0666221778901497,0.400013562759209
138,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.0670739631358091,0.400013562759209
139,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0689479766019549,0.40823154491661
140,WP_PLEURAL_MESOTHELIOMA,262,Down,0.0704923803898302,0.412582083824707
141,WP_KLEEFSTRA_SYNDROME,25,Down,0.0706853873867359,0.412582083824707
142,WP_FTO_OBESITY_VARIANT_MECHANISM,3,Up,0.0730472636340734,0.421555310463913
143,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.0732471560101331,0.421555310463913
144,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.0737866431849348,0.421711162091676
145,WP_SMALL_LIGAND_GPCRS,7,Down,0.0750149318446105,0.425774406262858
146,WP_BENZENE_METABOLISM,4,Up,0.0766268124835695,0.431944292287518
147,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.0784565961499016,0.434471451911092
148,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0786123471638536,0.434471451911092
149,WP_CYTOSINE_METHYLATION,7,Down,0.078658865534329,0.434471451911092
150,WP_OSTEOBLAST_SIGNALING,3,Down,0.0793763932220887,0.43551181081186
151,WP_PPARALPHA_PATHWAY,15,Up,0.0819163284858439,0.446471114859931
152,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0829074961779975,0.448900456279552
153,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0851232937873865,0.456399407567242
154,WP_AXON_GUIDANCE,39,Down,0.086482719568849,0.456399407567242
155,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.0870129039324083,0.456399407567242
156,WP_FOLATE_METABOLISM,40,Up,0.0870495869057682,0.456399407567242
157,WP_BREAST_CANCER_PATHWAY,90,Down,0.0870652575796561,0.456399407567242
158,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.0880036287034324,0.45839864824636
159,WP_PDGFRBETA_PATHWAY,28,Down,0.0919994181734761,0.476198246268999
160,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.0961372370297394,0.492989116575909
161,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.0964413703143638,0.492989116575909
162,WP_NAD_METABOLISM,12,Down,0.0982547454521365,0.495502156250085
163,WP_HISTONE_MODIFICATIONS,37,Up,0.0988492150533079,0.495502156250085
164,WP_INSULIN_SIGNALING,132,Down,0.0998915384622553,0.495502156250085
165,WP_POSTCOVID_NEUROINFLAMMATION,14,Down,0.100627791763655,0.495502156250085
166,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.101349078288831,0.495502156250085
167,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.102263492163268,0.495502156250085
168,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.102736031685759,0.495502156250085
169,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,33,Down,0.102944489081655,0.495502156250085
170,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Down,0.103076305403087,0.495502156250085
171,WP_FERROPTOSIS,52,Up,0.103361965889321,0.495502156250085
172,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,10,Down,0.103707930325712,0.495502156250085
173,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.104706827970668,0.495502156250085
174,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.105260536253708,0.495502156250085
175,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.105361940879423,0.495502156250085
176,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.107742278229019,0.503817585127743
177,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Up,0.109105557632795,0.505022118101671
178,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.110183669738285,0.505022118101671
179,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.11037953156392,0.505022118101671
180,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.112082837126864,0.505022118101671
181,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Down,0.112113203019912,0.505022118101671
182,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Down,0.112946286151499,0.505022118101671
183,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.113366362316568,0.505022118101671
184,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.113389684421444,0.505022118101671
185,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.113522590338772,0.505022118101671
186,WP_IL1_SIGNALING,54,Down,0.116232048644903,0.509664683290447
187,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.116514682503151,0.509664683290447
188,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.117681322878342,0.509664683290447
189,WP_FOCAL_ADHESION,123,Down,0.118533882676247,0.509664683290447
190,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.118591050102955,0.509664683290447
191,WP_MONOAMINE_GPCRS,3,Down,0.119406948010063,0.509664683290447
192,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.119520393529837,0.509664683290447
193,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.119520393529837,0.509664683290447
194,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.12059984489356,0.511616867770104
195,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,33,Down,0.125294380386564,0.528190689763055
196,WP_SEROTONIN_AND_ANXIETY,7,Down,0.125790249323887,0.528190689763055
197,WP_BASE_EXCISION_REPAIR,29,Down,0.127173347901703,0.53128764123402
198,WP_DOPAMINE_METABOLISM,7,Up,0.131109111603493,0.544963630553911
199,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.137585123206214,0.568322392574037
200,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,64,Down,0.13810993744205,0.568322392574037
201,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.140363234021283,0.574602723780288
202,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.141772745754374,0.574602723780288
203,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,46,Down,0.143352760721723,0.574602723780288
204,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.144123383578095,0.574602723780288
205,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.146894689527557,0.574602723780288
206,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.147159957923447,0.574602723780288
207,WP_AMINO_ACID_METABOLISM,60,Up,0.1482148797956,0.574602723780288
208,WP_NUCLEAR_RECEPTORS,21,Down,0.148395797898381,0.574602723780288
209,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.148832515230944,0.574602723780288
210,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.149015534973487,0.574602723780288
211,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.14932702950766,0.574602723780288
212,WP_LEPTIN_SIGNALING,70,Down,0.149446084342208,0.574602723780288
213,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.150277871298479,0.574602723780288
214,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.15035684160043,0.574602723780288
215,WP_NOTCH_SIGNALING_WP61,50,Down,0.150493242215274,0.574602723780288
216,WP_BARDETBIEDL_SYNDROME,65,Up,0.150807033215726,0.574602723780288
217,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.153769395457665,0.58159952540728
218,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Down,0.154234257283489,0.58159952540728
219,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.156023858028817,0.58159952540728
220,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.156434222381148,0.58159952540728
221,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,12,Down,0.156835060683795,0.58159952540728
222,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.157153937317509,0.58159952540728
223,WP_B_CELL_RECEPTOR_SIGNALING,88,Down,0.157713252483799,0.58159952540728
224,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,54,Down,0.158810097761593,0.58159952540728
225,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.159003515451565,0.58159952540728
226,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,70,Down,0.160411548128495,0.582950785662395
227,WP_PEPTIDE_GPCRS,15,Down,0.160789584866785,0.582950785662395
228,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Up,0.162843029765391,0.5862930004941
229,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.163136205483778,0.5862930004941
230,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.164242061504376,0.587700941817831
231,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.165013191878126,0.587904142492197
232,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Up,0.166950162690599,0.590383290174314
233,WP_STEROID_BIOSYNTHESIS,3,Up,0.169192320099434,0.590383290174314
234,WP_HEPATITIS_B_INFECTION,121,Down,0.169213809312925,0.590383290174314
235,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.170009209336553,0.590383290174314
236,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Up,0.171297156890018,0.590383290174314
237,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.171505531289645,0.590383290174314
238,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.17168379683411,0.590383290174314
239,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.171900194697915,0.590383290174314
240,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.172436295910697,0.590383290174314
241,WP_FRAGILE_X_SYNDROME,86,Down,0.172882591654933,0.590383290174314
242,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.175098935621317,0.595481090976626
243,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.176419583238913,0.597503362163068
244,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.178010300613055,0.599225702948012
245,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,42,Down,0.178580600420918,0.599225702948012
246,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.179172182018376,0.599225702948012
247,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Down,0.180888974109684,0.599225702948012
248,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.180891336481381,0.599225702948012
249,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.181296719360942,0.599225702948012
250,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.183011923487324,0.601680897066195
251,WP_NPHP1_DELETION_SYNDROME,10,Down,0.183501707367697,0.601680897066195
252,WP_IRON_METABOLISM_DISORDERS,14,Up,0.185969732419853,0.60548572236299
253,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.186133520969425,0.60548572236299
254,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,81,Down,0.187155179444576,0.606412254657032
255,WP_IDO_METABOLIC_PATHWAY,8,Up,0.188773486900692,0.609257175369684
256,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.19175160184205,0.61450134050902
257,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.193419572475009,0.61450134050902
258,WP_MALE_INFERTILITY,70,Up,0.195253270687245,0.61450134050902
259,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.195342287513586,0.61450134050902
260,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.195766687371737,0.61450134050902
261,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,28,Down,0.195961597788642,0.61450134050902
262,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,81,Down,0.196087493522464,0.61450134050902
263,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.196371631292676,0.61450134050902
264,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Down,0.201419132608291,0.627908886881149
265,WP_ENDOCHONDRAL_OSSIFICATION,27,Down,0.203365724832778,0.629210494501414
266,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Down,0.203365724832778,0.629210494501414
267,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.20505944624759,0.632074622703247
268,WP_CILIOPATHIES,129,Up,0.20656890551402,0.634351527007607
269,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Down,0.209012523234187,0.639469541344743
270,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,30,Down,0.210055888959454,0.640281468939373
271,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.210922556098958,0.640550788448128
272,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.213428630510561,0.64221585398108
273,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.213692296068511,0.64221585398108
274,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Up,0.214047216901618,0.64221585398108
275,WP_KININKALLIKREIN_PATHWAY,3,Up,0.215300431716285,0.64221585398108
276,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.215889195380356,0.64221585398108
277,WP_TRYPTOPHAN_METABOLISM,19,Up,0.216152845143085,0.64221585398108
278,WP_RAS_SIGNALING,121,Down,0.219146368951851,0.648767847652424
279,WP_HOMOLOGOUS_RECOMBINATION,12,Down,0.221714652873468,0.651949209990809
280,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.222105118831667,0.651949209990809
281,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.222597482390543,0.651949209990809
282,WP_IL18_SIGNALING,198,Up,0.225593310025625,0.654774384205116
283,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Down,0.225750274494807,0.654774384205116
284,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.225948876202008,0.654774384205116
285,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Down,0.22853589268477,0.659947507647598
286,WP_AGERAGE_PATHWAY,54,Down,0.231867253167915,0.667226396353825
287,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,15,Down,0.234833881961555,0.672978777402221
288,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,90,Down,0.235501686381336,0.672978777402221
289,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.238812337363708,0.677130354729088
290,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.239764582162679,0.677130354729088
291,WP_HEME_BIOSYNTHESIS,8,Down,0.239764582162679,0.677130354729088
292,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.240840220411776,0.677130354729088
293,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.241068279387148,0.677130354729088
294,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.242843908703943,0.679229798873421
295,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.243466331309428,0.679229798873421
296,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.244556724226877,0.679966837968649
297,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.245909880514207,0.68046395422167
298,WP_ENDOMETRIAL_CANCER,49,Down,0.246389135307482,0.68046395422167
299,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.247228639077271,0.680498896189278
300,WP_BLADDER_CANCER,29,Down,0.248961711367197,0.682984961517343
301,WP_NRXN1_DELETION_SYNDROME,3,Up,0.250031368920506,0.683640586782646
302,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,114,Down,0.251582636078225,0.68560433606748
303,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.254514906732853,0.688370908867702
304,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.254618515962795,0.688370908867702
305,WP_ADIPOGENESIS,88,Down,0.25600541189454,0.688370908867702
306,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,12,Up,0.257181486934056,0.688370908867702
307,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.257911253802518,0.688370908867702
308,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Down,0.258435995180137,0.688370908867702
309,WP_IL26_SIGNALING,33,Down,0.258452747071835,0.688370908867702
310,WP_TCELL_RECEPTOR_SIGNALING,76,Down,0.260194457474708,0.688581219510165
311,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Down,0.260214904886323,0.688581219510165
312,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,34,Down,0.261149707425829,0.688581219510165
313,WP_SPINA_BIFIDA,10,Down,0.262305260545955,0.688581219510165
314,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.26376342443355,0.688581219510165
315,WP_OREXIN_RECEPTOR_PATHWAY,122,Down,0.263981494824978,0.688581219510165
316,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Down,0.264826960171774,0.688581219510165
317,WP_GLIOBLASTOMA_SIGNALING,70,Down,0.26603019016492,0.688581219510165
318,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.266061759178897,0.688581219510165
319,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.267035507938972,0.688934868444432
320,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.268303772249032,0.69004376425298
321,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.271225935979942,0.693765943916901
322,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,75,Down,0.271436979272469,0.693765943916901
323,WP_ENERGY_METABOLISM,41,Down,0.275389679392644,0.698706744718717
324,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.275823966412256,0.698706744718717
325,WP_BDNFTRKB_SIGNALING,27,Down,0.275942324977357,0.698706744718717
326,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.277000546457901,0.698706744718717
327,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,94,Down,0.277614952032832,0.698706744718717
328,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Down,0.282538916994072,0.708931489896712
329,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.285332837723752,0.713765730840874
330,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.286481957458059,0.713848050920253
331,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.287100491925399,0.713848050920253
332,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,34,Down,0.288163912918787,0.714334037145064
333,WP_VITAMIN_D_METABOLISM,6,Down,0.289145921728163,0.714615896643477
334,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.290670118267898,0.715987912895715
335,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Down,0.291773383247098,0.715987912895715
336,WP_PROTEASOME_DEGRADATION,57,Down,0.29256693766321,0.715987912895715
337,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,88,Down,0.295202329570658,0.715987912895715
338,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.295916831829405,0.715987912895715
339,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.29625289571184,0.715987912895715
340,WP_CHEMOKINE_SIGNALING,111,Down,0.29887686686256,0.715987912895715
341,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.299069617837747,0.715987912895715
342,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.300649869209198,0.715987912895715
343,WP_PROLACTIN_SIGNALING,69,Down,0.301125844150224,0.715987912895715
344,WP_TAR_SYNDROME,46,Down,0.301714852715619,0.715987912895715
345,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.302933698563841,0.715987912895715
346,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Up,0.304033464038766,0.715987912895715
347,WP_KALLMANN_SYNDROME,11,Up,0.304175441866414,0.715987912895715
348,WP_IL9_SIGNALING,15,Up,0.304572859198716,0.715987912895715
349,WP_SYNAPTIC_VESICLE_PATHWAY,24,Down,0.305880386037005,0.715987912895715
350,WP_AFLATOXIN_B1_METABOLISM,3,Up,0.306188704813145,0.715987912895715
351,WP_ALZHEIMERS_DISEASE,187,Down,0.306230553267669,0.715987912895715
352,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,187,Down,0.306230553267669,0.715987912895715
353,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,32,Up,0.307688623415558,0.717008108414067
354,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,66,Up,0.309214415946715,0.717008108414067
355,WP_JOUBERT_SYNDROME,72,Up,0.309280532791001,0.717008108414067
356,WP_KCNQ2RELATED_EPILEPSIES,12,Up,0.310436390336652,0.717666149570406
357,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.311923923664847,0.719085123742771
358,WP_APOPTOSIS_MODULATION_AND_SIGNALING,80,Up,0.315461822214634,0.723916303069139
359,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.31648484898365,0.723916303069139
360,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.316658407174836,0.723916303069139
361,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.317902877858939,0.723987179136279
362,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,79,Down,0.318448795683272,0.723987179136279
363,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.319896125683983,0.72400365999351
364,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.321323707123316,0.72400365999351
365,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.321603151196162,0.72400365999351
366,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,21,Down,0.321974896181804,0.72400365999351
367,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.327190208403019,0.733726271159905
368,WP_MTHFR_DEFICIENCY,18,Up,0.330160281046862,0.736969220817809
369,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,16,Up,0.330427269115154,0.736969220817809
370,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Up,0.333218031086713,0.739715475038479
371,WP_TGFBETA_RECEPTOR_SIGNALING,37,Down,0.333456186195961,0.739715475038479
372,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.335126692796806,0.740905905497906
373,WP_DRAVET_SYNDROME,15,Down,0.33579332047475,0.740905905497906
374,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.338634214019701,0.74321299749136
375,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.338645047459611,0.74321299749136
376,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.342599029194836,0.745072616274967
377,WP_CELL_CYCLE,100,Down,0.343666251578523,0.745072616274967
378,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.343717989018043,0.745072616274967
379,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.344115601666322,0.745072616274967
380,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.344873919873591,0.745072616274967
381,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.344954689523543,0.745072616274967
382,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.346373617438388,0.745072616274967
383,WP_SELENIUM_MICRONUTRIENT_NETWORK,53,Up,0.347425583096532,0.745072616274967
384,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,85,Down,0.34767806379921,0.745072616274967
385,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,16,Down,0.348545513081242,0.745072616274967
386,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,54,Down,0.349566412015186,0.745319059814763
387,WP_RETT_SYNDROME,32,Down,0.356644790642663,0.757933201791509
388,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.358366822664393,0.757933201791509
389,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.359083259171739,0.757933201791509
390,WP_CIRCADIAN_RHYTHM_GENES,124,Down,0.359863383746695,0.757933201791509
391,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.360087341312855,0.757933201791509
392,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,55,Down,0.361591366602393,0.758010360066659
393,WP_CCL18_SIGNALING,22,Down,0.362027867276459,0.758010360066659
394,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.362887098257915,0.758010360066659
395,WP_CHOLESTASIS,9,Down,0.365627223753868,0.761800519365654
396,WP_FLUOROPYRIMIDINE_ACTIVITY,28,Up,0.368800278054005,0.765462665902006
397,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.36924505268906,0.765462665902006
398,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.37341543850922,0.76662416271352
399,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.373889342239029,0.76662416271352
400,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.374040613421816,0.76662416271352
401,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.37416241551615,0.76662416271352
402,WP_MELANOMA,55,Down,0.374462835250103,0.76662416271352
403,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.379530514645507,0.775071001372835
404,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,61,Down,0.380747378695506,0.775631417491092
405,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.383281879169774,0.778502170706736
406,WP_PURINE_METABOLISM,10,Down,0.384048458453141,0.778502170706736
407,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Down,0.385133642767414,0.778603401585414
408,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Up,0.389278922852339,0.778603401585414
409,WP_GLUTATHIONE_METABOLISM,12,Up,0.389882213070057,0.778603401585414
410,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.390933862052845,0.778603401585414
411,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.391080964712716,0.778603401585414
412,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.391224400958465,0.778603401585414
413,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.391537539739706,0.778603401585414
414,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.392474612980762,0.778603401585414
415,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,26,Down,0.392658131917166,0.778603401585414
416,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.394645665317369,0.778603401585414
417,WP_ID_SIGNALING,12,Down,0.396469863787329,0.778603401585414
418,WP_RETINOBLASTOMA_GENE_IN_CANCER,76,Down,0.396661681978419,0.778603401585414
419,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.398845246611334,0.778603401585414
420,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Down,0.399830388363948,0.778603401585414
421,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.400788229773887,0.778603401585414
422,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.401932256625655,0.778603401585414
423,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,46,Up,0.402665632161505,0.778603401585414
424,WP_OSTEOCLAST_SIGNALING,9,Down,0.40431870566728,0.778603401585414
425,WP_GALANIN_RECEPTOR_PATHWAY,12,Down,0.405577469223285,0.778603401585414
426,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,130,Up,0.406113663786953,0.778603401585414
427,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.406347951698042,0.778603401585414
428,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.406915876820581,0.778603401585414
429,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.407618525956787,0.778603401585414
430,WP_OXIDATION_BY_CYTOCHROME_P450,16,Up,0.407818517087932,0.778603401585414
431,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.410163319844713,0.778603401585414
432,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,40,Up,0.411177560566997,0.778603401585414
433,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.411753286227674,0.778603401585414
434,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.413947770503882,0.778603401585414
435,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.413961574950851,0.778603401585414
436,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.414548492705679,0.778603401585414
437,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,128,Down,0.415645127159588,0.778603401585414
438,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.416495729547839,0.778603401585414
439,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.416507656650303,0.778603401585414
440,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Down,0.417179720009674,0.778603401585414
441,WP_ATR_SIGNALING,10,Up,0.417210328188539,0.778603401585414
442,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.419232508112273,0.780607136145703
443,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.422263688818568,0.783199423123258
444,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.422527999838064,0.783199423123258
445,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.424206418621907,0.784543556237819
446,WP_OVARIAN_INFERTILITY,23,Down,0.426661457891127,0.784658468247104
447,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.430143468453698,0.784658468247104
448,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.430158601863438,0.784658468247104
449,WP_ACUTE_VIRAL_MYOCARDITIS,69,Down,0.430644163435953,0.784658468247104
450,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.430737699649113,0.784658468247104
451,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.431037410250612,0.784658468247104
452,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.431546701706493,0.784658468247104
453,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.432615143985397,0.784658468247104
454,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.432849264379326,0.784658468247104
455,WP_HIPPOYAP_SIGNALING,16,Down,0.437553992620073,0.790828770451995
456,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.438174871599161,0.790828770451995
457,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,100,Up,0.43986200477156,0.792136608155348
458,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.441587926114512,0.793508434917562
459,WP_RANKLRANK_SIGNALING,49,Up,0.443745329159646,0.793546706079351
460,WP_HUNGER_AND_SATIETY,2,Up,0.444565437521984,0.793546706079351
461,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,23,Up,0.444791287850288,0.793546706079351
462,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.448043892292505,0.793546706079351
463,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.448045018682955,0.793546706079351
464,WP_ENDODERM_DIFFERENTIATION,85,Down,0.449056038552988,0.793546706079351
465,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Up,0.449431770994545,0.793546706079351
466,WP_SERINE_METABOLISM,7,Down,0.4494470888678,0.793546706079351
467,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Down,0.450786404195668,0.793546706079351
468,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.451251346834916,0.793546706079351
469,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,25,Up,0.453293240276223,0.795437818224588
470,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.456889708022555,0.797341502638715
471,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,67,Down,0.457178437233115,0.797341502638715
472,WP_G_PROTEIN_SIGNALING,62,Down,0.457889197992478,0.797341502638715
473,WP_13Q1212_COPY_NUMBER_VARIATION,21,Up,0.45825337879479,0.797341502638715
474,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.461557680789516,0.801396563902472
475,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.463236667689318,0.802618478964861
476,WP_SMALL_CELL_LUNG_CANCER,73,Up,0.46654444491843,0.805652214073839
477,WP_TGFB_SMAD_SIGNALING,8,Up,0.46697864047398,0.805652214073839
478,WP_EFFECTS_OF_MFN2_MUTATION,18,Down,0.467924372208135,0.805652214073839
479,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,50,Down,0.469326954242907,0.806240968842545
480,WP_NEPHROGENESIS,4,Up,0.470225595436721,0.806240968842545
481,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.471518839481721,0.806777556951053
482,WP_RAC1PAK1P38MMP2_PATHWAY,53,Down,0.474933136777133,0.808727479137816
483,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.475202163396549,0.808727479137816
484,WP_OXIDATIVE_DAMAGE_RESPONSE,36,Up,0.475606439735969,0.808727479137816
485,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,64,Down,0.479518046601252,0.812315088594459
486,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.480852028728284,0.812315088594459
487,WP_DNA_DAMAGE_RESPONSE,60,Down,0.481219492678277,0.812315088594459
488,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,13,Up,0.48166435386889,0.812315088594459
489,WP_ALSTROM_SYNDROME,27,Down,0.484024758631048,0.814626536509923
490,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.487123851685539,0.818062688445928
491,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.491250595263672,0.818062688445928
492,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.49215535377633,0.818062688445928
493,WP_ACUTE_MYELOID_LEUKEMIA,57,Up,0.492392988993524,0.818062688445928
494,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.492594240711425,0.818062688445928
495,WP_IL3_SIGNALING,46,Up,0.494608714145683,0.818062688445928
496,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.494848989070072,0.818062688445928
497,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.49678386614053,0.818062688445928
498,WP_LUNG_PATHOLOGY_OF_COVID19,17,Down,0.496991103144261,0.818062688445928
499,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.499467936962263,0.818062688445928
500,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.499515644538845,0.818062688445928
501,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Up,0.499867432018425,0.818062688445928
502,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.499890813174294,0.818062688445928
503,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,9,Down,0.499982420763429,0.818062688445928
504,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,14,Down,0.50552456724881,0.824800064747138
505,WP_NUCLEOTIDE_GPCRS,6,Up,0.506104535476676,0.824800064747138
506,WP_VEGFAVEGFR2_SIGNALING,348,Down,0.509681254528223,0.827299033119554
507,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,14,Up,0.510479352706901,0.827299033119554
508,WP_ASPIRIN_AND_MIRNAS,8,Down,0.511683827982765,0.827299033119554
509,WP_IL10_ANTIINFLAMMATORY_SIGNALING,12,Up,0.512211967096862,0.827299033119554
510,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,19,Down,0.512664042394863,0.827299033119554
511,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.516304300115577,0.829700174674197
512,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.516420407156267,0.829700174674197
513,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.517176415076383,0.829700174674197
514,WP_TRANSSULFURATION_PATHWAY,8,Down,0.51844285097141,0.830113747761615
515,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.519792254252244,0.830658301455527
516,WP_VITAMIN_D_RECEPTOR_PATHWAY,86,Down,0.521078280770854,0.831099660996925
517,WP_MEASLES_VIRUS_INFECTION,104,Up,0.525053677715034,0.834086118082278
518,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.525862873975958,0.834086118082278
519,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Down,0.525991124282749,0.834086118082278
520,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.530311594891596,0.837710414018007
521,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.530312424912979,0.837710414018007
522,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,42,Up,0.533636034830236,0.840415109153869
523,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.534509976931887,0.840415109153869
524,WP_4P163_COPY_NUMBER_VARIATION,22,Down,0.535088113240131,0.840415109153869
525,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Down,0.54040650888924,0.845631479232166
526,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.543571357635522,0.845631479232166
527,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.543996912040596,0.845631479232166
528,WP_METHYLATION_PATHWAYS,5,Up,0.546182441383781,0.845631479232166
529,WP_TNFALPHA_SIGNALING,86,Down,0.546723231224347,0.845631479232166
530,WP_TCELL_ACTIVATION_SARSCOV2,64,Up,0.546787575074285,0.845631479232166
531,WP_SILDENAFIL_TREATMENT,12,Up,0.547187580385468,0.845631479232166
532,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.547341758218772,0.845631479232166
533,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.547960113800074,0.845631479232166
534,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Up,0.548910333339466,0.845631479232166
535,WP_MRNA_PROCESSING,124,Down,0.549711836438893,0.845631479232166
536,WP_PREGNANE_X_RECEPTOR_PATHWAY,14,Up,0.551764517572078,0.84720559321235
537,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.55482670560249,0.850321003185938
538,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Up,0.562500335377578,0.858392538499712
539,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,12,Down,0.563119576222283,0.858392538499712
540,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Down,0.563222321737356,0.858392538499712
541,WP_IL17_SIGNALING,25,Up,0.567072018087875,0.862662238237193
542,WP_BLOOD_CLOTTING_CASCADE,10,Down,0.569661201722227,0.865002156858659
543,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.576479271259941,0.871567783696913
544,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.576479271259941,0.871567783696913
545,WP_METABOLIC_EPILEPTIC_DISORDERS,59,Down,0.577162141087263,0.871567783696913
546,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.578994461258438,0.872627769295627
547,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.580568683857487,0.872627769295627
548,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.58104497882625,0.872627769295627
549,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.584185972208327,0.875746912800461
550,WP_IL6_SIGNALING,40,Down,0.587772866475841,0.876680560516463
551,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.589136413558378,0.876680560516463
552,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.589809206101389,0.876680560516463
553,WP_KREBS_CYCLE_DISORDERS,11,Down,0.591105276304051,0.876680560516463
554,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Down,0.593447569334488,0.876680560516463
555,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,75,Down,0.593685070948424,0.876680560516463
556,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,34,Down,0.593826870673507,0.876680560516463
557,WP_ANGIOGENESIS,15,Up,0.595740856855525,0.876680560516463
558,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,17,Down,0.596443939911784,0.876680560516463
559,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.597501432086818,0.876680560516463
560,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.598096041111848,0.876680560516463
561,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.598096041111848,0.876680560516463
562,WP_DNA_REPLICATION,37,Down,0.599183577635758,0.876680560516463
563,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,39,Down,0.599721938725114,0.876680560516463
564,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.602801944761025,0.877564120488547
565,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.6032183291249,0.877564120488547
566,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,31,Up,0.603525263908284,0.877564120488547
567,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Down,0.606601778178973,0.880481946104576
568,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.609990845904899,0.883842370034739
569,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.617275794728909,0.89166531324267
570,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.617556778309018,0.89166531324267
571,WP_IL4_SIGNALING,51,Down,0.619314668707166,0.891779952931882
572,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.620046423608078,0.891779952931882
573,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.621607502863563,0.891779952931882
574,WP_HIPPO_SIGNALING_REGULATION,46,Down,0.623585099308656,0.891779952931882
575,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.625896347247347,0.891779952931882
576,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.628615702967363,0.891779952931882
577,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.628884543478087,0.891779952931882
578,WP_VITAMIN_B12_DISORDERS,9,Up,0.629115559918844,0.891779952931882
579,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,10,Up,0.629260850027476,0.891779952931882
580,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Down,0.62944826628125,0.891779952931882
581,WP_GPR40_PATHWAY,10,Up,0.629555471024815,0.891779952931882
582,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Down,0.633022808389662,0.892638438757721
583,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.633479361843478,0.892638438757721
584,WP_TP53_NETWORK,16,Up,0.634233775730949,0.892638438757721
585,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.634499983807129,0.892638438757721
586,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.63774617300248,0.895674232732152
587,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.640873276873244,0.898532720386166
588,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Down,0.642300920723387,0.899002819311815
589,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,14,Down,0.644450037411418,0.900479424090997
590,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.648262392345582,0.903687993062116
591,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,50,Up,0.649143992805821,0.903687993062116
592,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.650040451874572,0.903687993062116
593,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,19,Up,0.651550146620259,0.903933145228027
594,WP_IL5_SIGNALING,37,Down,0.652413472983534,0.903933145228027
595,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.655137918569305,0.904535604292962
596,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.655805720089793,0.904535604292962
597,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.657878503999042,0.904535604292962
598,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.658041131899471,0.904535604292962
599,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.658343653671305,0.904535604292962
600,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.660508277406044,0.905997187175291
601,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.664401463211745,0.909820972085302
602,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.667606281808682,0.911376281427157
603,WP_ONECARBON_METABOLISM,23,Down,0.667752002066313,0.911376281427157
604,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.669042348526483,0.911493647543922
605,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.672194938597623,0.911493647543922
606,WP_PRION_DISEASE_PATHWAY,28,Down,0.673215392787465,0.911493647543922
607,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.674088429433376,0.911493647543922
608,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.674181502655357,0.911493647543922
609,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.674483148668589,0.911493647543922
610,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Up,0.675858410641676,0.911854872062458
611,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,45,Down,0.678190634274809,0.913470865039966
612,WP_CELLULAR_PROTEOSTASIS,6,Up,0.680075742602064,0.913470865039966
613,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.68038595415492,0.913470865039966
614,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.68340723561906,0.913920191423306
615,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.684383470230156,0.913920191423306
616,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.685296294993129,0.913920191423306
617,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.685827113998678,0.913920191423306
618,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.686272999148971,0.913920191423306
619,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.690117802462169,0.915038421550661
620,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.690343201975167,0.915038421550661
621,WP_ENDOTHELIN_PATHWAYS,13,Down,0.690448189286708,0.915038421550661
622,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,52,Up,0.691995719416853,0.91507011265258
623,WP_FOXA2_PATHWAY,10,Up,0.692695844693266,0.91507011265258
624,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.694968921895879,0.916601638974854
625,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,25,Up,0.696500338311653,0.917151645488785
626,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.6995316502758,0.919456652987885
627,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.701395952392352,0.919456652987885
628,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Down,0.701602403495008,0.919456652987885
629,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Down,0.703344718905967,0.920197774282796
630,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.704404128551836,0.920197774282796
631,WP_CILIARY_LANDSCAPE,186,Down,0.705613867294902,0.920317294427424
632,WP_IL7_SIGNALING,23,Up,0.710251541460009,0.92434279959508
633,WP_CORI_CYCLE,11,Down,0.710946527513591,0.92434279959508
634,WP_IL19_SIGNALING,20,Down,0.71491895392345,0.92804148119716
635,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.717133978959396,0.929450810525327
636,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.719347121297626,0.930853271742054
637,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Down,0.723807909076481,0.935155273422203
638,WP_ATM_SIGNALING,35,Up,0.726074054421434,0.936359669745599
639,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.727724213873041,0.936359669745599
640,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.730295587316465,0.936359669745599
641,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.731919758549781,0.936359669745599
642,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.734574060939916,0.936359669745599
643,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,13,Up,0.735052035932572,0.936359669745599
644,WP_ESTROGEN_METABOLISM_WP697,6,Up,0.737574053548663,0.936359669745599
645,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Up,0.737799464867996,0.936359669745599
646,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.73833823005943,0.936359669745599
647,WP_PI3KAKT_SIGNALING,186,Up,0.740356557170272,0.936359669745599
648,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,35,Up,0.740463513460115,0.936359669745599
649,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,147,Up,0.741109356909418,0.936359669745599
650,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.741704256009618,0.936359669745599
651,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.742725836901207,0.936359669745599
652,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.743178310210288,0.936359669745599
653,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,74,Down,0.743363390088986,0.936359669745599
654,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.744665996483212,0.936359669745599
655,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.746570388087928,0.936359669745599
656,WP_IL2_SIGNALING,37,Down,0.747774398582644,0.936359669745599
657,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.748778662456195,0.936359669745599
658,WP_NUCLEAR_RECEPTORS_METAPATHWAY,184,Up,0.750750700776066,0.936359669745599
659,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,49,Up,0.750785183038782,0.936359669745599
660,WP_MONOAMINE_TRANSPORT,12,Down,0.750908119115548,0.936359669745599
661,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,78,Down,0.757133972111039,0.942694794322822
662,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.760693691201024,0.945696235435715
663,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.762840041403369,0.946133848838697
664,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,41,Up,0.76334492786014,0.946133848838697
665,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.765989207906673,0.947315912293355
666,WP_GLYOXYLATE_METABOLISM,5,Down,0.766600726108596,0.947315912293355
667,WP_NONSMALL_CELL_LUNG_CANCER,61,Down,0.768626866681608,0.947538386062741
668,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.770524438447262,0.947538386062741
669,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.772171272888764,0.947538386062741
670,WP_DNA_MISMATCH_REPAIR,21,Down,0.773165737273989,0.947538386062741
671,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.773440368959868,0.947538386062741
672,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Down,0.776724786884268,0.947538386062741
673,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.776941451705249,0.947538386062741
674,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,33,Down,0.777075301781354,0.947538386062741
675,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.7771426617161,0.947538386062741
676,WP_KIT_RECEPTOR_SIGNALING,53,Down,0.778385353308323,0.947649623924186
677,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,4,Up,0.780876667647366,0.949278430537344
678,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.782039033851852,0.949289269705125
679,WP_ULCERATIVE_COLITIS_SIGNALING,13,Up,0.789873292851633,0.957386921968917
680,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.793977041543448,0.957654977935489
681,WP_SLEEP_REGULATION,11,Down,0.795816767019582,0.957654977935489
682,WP_MIRNA_BIOGENESIS,6,Down,0.79595668711865,0.957654977935489
683,WP_CREATINE_PATHWAY,3,Up,0.796109407113743,0.957654977935489
684,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.798677638597291,0.957654977935489
685,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.80050001821455,0.957654977935489
686,WP_CANCER_PATHWAYS,320,Down,0.801437780542262,0.957654977935489
687,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,20,Up,0.802850232650563,0.957654977935489
688,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,17,Down,0.80364173156183,0.957654977935489
689,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.804143279139539,0.957654977935489
690,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Up,0.806027921953274,0.957654977935489
691,WP_GLUCURONIDATION,7,Down,0.807268755294954,0.957654977935489
692,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,27,Down,0.808137756637376,0.957654977935489
693,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,22,Down,0.808165778827598,0.957654977935489
694,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.808462614640591,0.957654977935489
695,WP_APOPTOSIS,74,Up,0.810586784658718,0.957654977935489
696,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.811606265251242,0.957654977935489
697,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.811996275222891,0.957654977935489
698,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.813606429655799,0.957654977935489
699,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.815101140618244,0.957654977935489
700,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,31,Up,0.81530249060572,0.957654977935489
701,WP_CYTOSOLIC_DNASENSING_PATHWAY,55,Down,0.815693972700823,0.957654977935489
702,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.81949899416281,0.959145831775885
703,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.819513760042723,0.959145831775885
704,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.821881847981785,0.959145831775885
705,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.822403102404236,0.959145831775885
706,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,23,Up,0.823140396084103,0.959145831775885
707,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.824058490114092,0.959145831775885
708,WP_PYRIMIDINE_METABOLISM,75,Down,0.825121809109753,0.959145831775885
709,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Down,0.827045512199438,0.960026031791449
710,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.82950669499768,0.961526774624071
711,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.834154623788009,0.96555450826657
712,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.835870263600336,0.966181498515556
713,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.837737351892572,0.966981543629153
714,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.840790961168661,0.969147004260235
715,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,30,Down,0.844468872996745,0.970551311004584
716,WP_LUNG_FIBROSIS,35,Up,0.844848368965206,0.970551311004584
717,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.847758556949829,0.970551311004584
718,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Down,0.849033264221231,0.970551311004584
719,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.850443141165945,0.970551311004584
720,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Down,0.85150758361129,0.970551311004584
721,WP_FOXP3_IN_COVID19,10,Down,0.852640796179274,0.970551311004584
722,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.853066779022903,0.970551311004584
723,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.853803650843356,0.970551311004584
724,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.855033092909748,0.970551311004584
725,WP_ALLOGRAFT_REJECTION,53,Up,0.856855984760471,0.970551311004584
726,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.857736293777849,0.970551311004584
727,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.858490438593446,0.970551311004584
728,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,24,Down,0.858519264169304,0.970551311004584
729,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.860571423572296,0.971536737448559
730,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,42,Down,0.863740618885537,0.9737788073189
731,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,38,Up,0.866933735091721,0.97604167439191
732,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.869828342595963,0.977155678164476
733,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.870861476598992,0.977155678164476
734,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.873752117582671,0.977155678164476
735,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,17,Down,0.876025119181314,0.977155678164476
736,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.876160096882386,0.977155678164476
737,WP_PREIMPLANTATION_EMBRYO,22,Down,0.880151163361445,0.977155678164476
738,WP_AEROBIC_GLYCOLYSIS,10,Up,0.880692286626061,0.977155678164476
739,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.880692286626061,0.977155678164476
740,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.881798648467064,0.977155678164476
741,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Down,0.881831612565148,0.977155678164476
742,WP_TRANSLATION_FACTORS,49,Down,0.882089799115151,0.977155678164476
743,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Up,0.882170922085304,0.977155678164476
744,WP_PURINERGIC_SIGNALING,16,Up,0.888073929661356,0.978404471299631
745,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.888866169501047,0.978404471299631
746,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,50,Up,0.889285240380913,0.978404471299631
747,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.889964773480371,0.978404471299631
748,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Up,0.890705588865012,0.978404471299631
749,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.891328832538067,0.978404471299631
750,WP_THERMOGENESIS,75,Up,0.891834683649166,0.978404471299631
751,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,280,Up,0.896071119509454,0.978404471299631
752,WP_EICOSANOID_SYNTHESIS,14,Down,0.896710434174818,0.978404471299631
753,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,182,Up,0.898339165643419,0.978404471299631
754,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.899777108459292,0.978404471299631
755,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.900556263788503,0.978404471299631
756,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.901785466633893,0.978404471299631
757,WP_NEPHROTIC_SYNDROME,29,Down,0.902948873209331,0.978404471299631
758,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Down,0.903305158401679,0.978404471299631
759,WP_AUTOPHAGY,27,Down,0.904197840211307,0.978404471299631
760,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.90454425993582,0.978404471299631
761,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.905643616692556,0.978404471299631
762,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.905886035395284,0.978404471299631
763,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.908083568259063,0.979025528069949
764,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,22,Down,0.90884022289847,0.979025528069949
765,WP_ALPHA_6_BETA_4_SIGNALING,27,Down,0.910655292934706,0.979698439327141
766,WP_IL11_SIGNALING,41,Up,0.911858501683868,0.979712202200814
767,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.917076469078455,0.982241484030126
768,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,9,Up,0.919229084395958,0.982241484030126
769,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.922036237491354,0.982241484030126
770,WP_BURN_WOUND_HEALING,63,Up,0.92270120361649,0.982241484030126
771,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Up,0.923052494828226,0.982241484030126
772,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.923513452626999,0.982241484030126
773,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.925538703223242,0.982241484030126
774,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,171,Up,0.92603186838188,0.982241484030126
775,WP_ARYLAMINE_METABOLISM,1,Up,0.926124600360559,0.982241484030126
776,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.926147498915404,0.982241484030126
777,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,6,Down,0.929740336902295,0.983420732907926
778,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.931067210640825,0.983420732907926
779,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Up,0.931147194620989,0.983420732907926
780,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.93282133367573,0.983420732907926
781,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.933552408586756,0.983420732907926
782,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.934428934549208,0.983420732907926
783,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.935685500518306,0.983485526087569
784,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.939665635377727,0.984637073014346
785,WP_ESTROGEN_SIGNALING,21,Down,0.940215702857251,0.984637073014346
786,WP_RETINOL_METABOLISM,7,Up,0.9403702787233,0.984637073014346
787,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.941713883616664,0.984791011710946
788,WP_PRIMARY_OVARIAN_INSUFFICIENCY,95,Down,0.945304406622661,0.98729127747519
789,WP_5Q35_COPY_NUMBER_VARIATION,78,Down,0.95092537224343,0.990015865071638
790,WP_NETRINUNC5B_SIGNALING,36,Up,0.953202187478935,0.990015865071638
791,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,49,Down,0.955752046649245,0.990015865071638
792,WP_ECTODERM_DIFFERENTIATION,80,Up,0.956472493204142,0.990015865071638
793,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.957694183863406,0.990015865071638
794,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Down,0.958190246230139,0.990015865071638
795,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.959271321736854,0.990015865071638
796,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.959739334347818,0.990015865071638
797,WP_CAMKK2_PATHWAY,30,Down,0.962834452406086,0.990015865071638
798,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.964845598220419,0.990015865071638
799,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.964870088737142,0.990015865071638
800,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,35,Down,0.965064523309944,0.990015865071638
801,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,22,Up,0.965886381746857,0.990015865071638
802,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.968439418949333,0.990015865071638
803,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.969510310672595,0.990015865071638
804,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.971144258414073,0.990015865071638
805,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.971476307140527,0.990015865071638
806,WP_VALPROIC_ACID_PATHWAY,9,Up,0.972465625593649,0.990015865071638
807,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.973039654708169,0.990015865071638
808,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.973458415756805,0.990015865071638
809,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.974847231177774,0.990015865071638
810,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.975231581574936,0.990015865071638
811,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.976592783043324,0.990015865071638
812,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.977585501055181,0.990015865071638
813,WP_MESODERMAL_COMMITMENT_PATHWAY,79,Down,0.977986510696527,0.990015865071638
814,WP_TOLLLIKE_RECEPTOR_SIGNALING,82,Up,0.981259866106114,0.990938503865107
815,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.981306051822676,0.990938503865107
816,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.982935623171823,0.991367668958836
817,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,16,Up,0.987642236855469,0.994895423417443
818,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Up,0.991048115685829,0.995575735652075
819,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,14,Down,0.991079502141554,0.995575735652075
820,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.991946662496599,0.995575735652075
821,WP_OSTEOPONTIN_SIGNALING,11,Down,0.995094992442953,0.997519097174849
822,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.997567842717548,0.998781428900903
823,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.999851809464382,0.999851809464382
